Status: Not yet recruiting
Market Research of a Slow Release Protein Substitute for the Dietary Management of PKU
XPhePiccosMR is a prospective, single-arm, open label, observational study that aims to evaluate the acceptability and tolerability of XPhe Piccos, a slow-release, phenylalanine-free protein substitute in the form of tiny tablets, for use in the dietary management of phenylketonuria (PKU) in children aged three years and older.
Participants needed: 10
Trial details
Age: 3-18Biological sex: AllType: InterventionalSponsor: metaX Institut fuer Diatetik GmbHUpdated: Oct 9, 2026Locations: 1
Eligibility criteria
Diagnosis of PKU or HPA requiring a phenylalanine-free protein substitute. [+3]
Presence of serious concurrent illness. [+4]